Wednesday, May 15, 2024
HomeHealthcareHospital and illnessGlenmark signs deal with AstraZeneca to market its Pulmicort Respules® in Colombia
dailyadvent.com
Hospital and illness

Glenmark signs deal with AstraZeneca to market its Pulmicort Respules® in Colombia

Sarojini P
By Sarojini P

-

California, USA (CU)_ Glenmark Pharmaceuticals Ltd. (GPL) is a global pharmaceutical firm that operates in the specialty, generics, and OTC segments. Glenmark’s global focus is on three core therapeutic areas such as……

spot_img
Previous article
Mithra and Searchlight Pharma join hands to launch Haloette in Canada
Next article
Introduction of eye-care medications to alleviate effects of digital eye strain
Sarojini P
Sarojini Phttps://www.commonwealthunion.com/

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

Follow us

51,000FansLike
50FollowersFollow
428SubscribersSubscribe
spot_img

First and only digital business platform reaching out to 2.4 billion in the Commonwealth.

Contact us: info@commonwealthunion.com

Trending

Categories

© All rights reserved by Commonwealth Union

MORE STORIES
Canada and Caribbean

Immigration protest shakes P.E.I.

Upeksha Nanayakkara - 0
Some migrant workforces are ready to go on a hunger strike if Canada’s Prince Edward Island (P.E.I.) government does not inverse some current changes...